Study warns diabetic 'yo-yo' dieting can hurt kidneys in those with type 1 diabetes
"Yo-yo" dieting --- repeatedly losing and gaining weight -- can significantly increase risk of kidney disease among people ...
Neurology Advisor2h
Leqembi Monthly IV Maintenance Dosing Approved for Early Alzheimer Disease
The FDA has approved the sBLA for once every 4 weeks lecanemab-irmb (Leqembi®) intravenous maintenance dosing.
Prescriptions for weight loss drugs are skyrocketing, especially among young women. Experts think they know why.
The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating." ...
States Eye Canadian Drug Imports Despite Delays, Tariff Threats
State leaders are reviving talk of importing prescription drugs from Canada, even as US drugmakers and health-care attorneys ...
Medscape6h
Warning of Confusion Between Nasal and IV Epinephrine
Confusion between approved injectable epinephrine products and unapproved nasal solutions has prompted a warning to healthcare providers and a recall by one manufacturer, according to a January ...
JD Supra17h
The Future of Telemedicine Prescribing Comes Into Focus: New Final and Proposed Rules
On January 17, the Drug Enforcement Administration (DEA) and the U.S. Department of Health and Human Services (HHS) jointly published two final ...
Sanjay Gupta: New non-opioid pain medication ‘a pretty big deal’
Dr. Sanjay Gupta said Tuesday that the approval of a new non-opioid pain medication is “a pretty big deal.” “This is a pretty ...
With FDA approval, Genentech turns eye implant's focus to diabetes
Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...
verywellhealth19h
6 Pregnancy-Safe Nausea Medications to Take for Morning Sickness
Certain nausea medicines, such as pyridoxine (vitamin B6) and Unisom (doxylamine), are safe to take during pregnancy to help ease morning sickness symptoms.
Business Wire20h
FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Leading Cause of Diabetes-Related Blindness
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...
Times News21h
FDA approves painkiller designed to eliminate risk of addiction
Federal officials have approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin. The U.S.